Michael B. Cramer

A randomized, double-blind comparison of single-dose and divided multiple-dose dolasetron for cisplatin-induced emesis

G. S. Harman, George Omura, Kevin Ryan et al. · Cancer Chemotherapy and Pharmacology · 1996 · 40 citations

Pharmacy, Oncology, Pharmacotherapy +10

A Double‐Blind, Placebo‐Controlled, Dose‐Ranging Safety Evaluation of Single‐Dose Intravenous Dolasetron in Healthy Male Volunteers

Thomas L. Hunt, Michael B. Cramer, Ajit Shah et al. · The Journal of Clinical Pharmacology · 1995 · 38 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Dose-ranging evaluation of the antiemetic efficacy of intravenous dolasetron in patients receiving chemotherapy with doxorubicin or cyclophosphamide

Paul J. Hesketh, David R. Gandara, Ann M. Hesketh et al. · Supportive Care in Cancer · 1996 · 33 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Single‐Dose, Placebo‐Controlled, Phase I Study of Oral Dolasetron

Russell M. Dixon, Michael B. Cramer, Ajit Shah et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 1996 · 22 citations

Medicine, Pharmacology, Pharmacotherapy +13

Antiemetic Efficacy of Two Different Single Intravenous Doses of Dolasetron in Patients Receiving High-Dose Cisplatin-Containing Chemotherapy

Allen Yeilding, Luigi F. Bertoli, Peter D. Eisenberg et al. · American Journal of Clinical Oncology · 1996 · 22 citations

Medicine, Pharmacology, Pharmacotherapy +13